Pileri A - Search Results

1

Patients with high-risk aggressive lymphoma treated with frontline intensive chemotherapy and autografting: evidence of marked differences in outcome between patients with age-adjusted International Prognostic Index scores 2 and 3.

Cuttica A, Zallio F, Ladetto M, Di Nicola M, Caracciolo D, Magni M, Marinone C, Dell'Aquila M, Rosace M, Pileri A, Boccadoro M, Gianni AM, Tarella C. Cuttica A, et al. Among authors: pileri a. Cancer. 2003 Sep 1;98(5):983-92. doi: 10.1002/cncr.11610. Cancer. 2003. PMID: 12942566 Free article.

2

[Kinetic and immunological studies in human myeloma: clinical implications (author's transl)].

Pileri A, Boccadoro M. Pileri A, et al. Haematologica. 1979 Oct;64 Suppl:30-4. Haematologica. 1979. PMID: 120281 Italian. No abstract available.

3

[Kinetic and immunological considerations on the therapy of immunoproliferative disorders].

Pileri A, Boccadoro M, Conte P. Pileri A, et al. Recenti Prog Med. 1979 Feb;66(2):103-15. Recenti Prog Med. 1979. PMID: 375339 Review. Italian. No abstract available.

4

Granulocyte-macrophage colony-stimulating factor or granulocyte colony-stimulating factor infusion makes high-dose etoposide a safe outpatient regimen that is effective in lymphoma and myeloma patients.

Gianni AM, Bregni M, Siena S, Magni M, Di Nicola M, Lombardi F, Tarella C, Pileri A, Bonadonna G. Gianni AM, et al. Among authors: pileri a. J Clin Oncol. 1992 Dec;10(12):1955-62. doi: 10.1200/JCO.1992.10.12.1955. J Clin Oncol. 1992. PMID: 1280674

5

Multiple myeloma: intensified maintenance therapy with recombinant interferon-alpha-2b plus glucocorticoids.

Palumbo A, Boccadoro M, Garino LA, Gallone G, Frieri R, Pileri A. Palumbo A, et al. Among authors: pileri a. Eur J Haematol. 1992 Aug;49(2):93-7. doi: 10.1111/j.1600-0609.1992.tb00037.x. Eur J Haematol. 1992. PMID: 1397246 Clinical Trial.

6

Cyclosporin A and dipyridamole: an effective combination against the generation of cytotoxic T lymphocytes (CTL).

Massaia M, Bianchi A, Attisano C, Dianzani U, Boccadoro M, Pileri A. Massaia M, et al. Among authors: pileri a. Pharmacol Res. 1992 Sep;26 Suppl 2:12-3. doi: 10.1016/1043-6618(92)90576-w. Pharmacol Res. 1992. PMID: 1409272 No abstract available.

7

Multiple independent immunoglobulin class-switch recombinations occurring within the same clone in myeloma.

Palumbo A, Battaglio S, Astolfi M, Frieri R, Boccadoro M, Pileri A. Palumbo A, et al. Among authors: pileri a. Br J Haematol. 1992 Dec;82(4):676-80. doi: 10.1111/j.1365-2141.1992.tb06943.x. Br J Haematol. 1992. PMID: 1482654

8

Early disappearance of murine plasmocytoma stem cells in long-term bone marrow culture.

Tarella C, Omedè P, Boccadoro M, Palumbo A, Battaglio S, Pileri A. Tarella C, et al. Among authors: pileri a. Leuk Res. 1992 Aug;16(8):743-50. doi: 10.1016/0145-2126(92)90152-w. Leuk Res. 1992. PMID: 1528062

9

Standard chemotherapy for myelomatosis: an area of great controversy.

Boccadoro M, Pileri A. Boccadoro M, et al. Among authors: pileri a. Hematol Oncol Clin North Am. 1992 Apr;6(2):371-82. Hematol Oncol Clin North Am. 1992. PMID: 1582979 Review.

10

MACOP-B treatment for intermediate and high-grade non-Hodgkin's lymphomas at diagnosis and in relapse.

Tarella C, Gallo E, Ferrero D, Badoni R, Carlesso N, Caracciolo D, Pileri A. Tarella C, et al. Among authors: pileri a. Haematologica. 1990 Mar-Apr;75(2):149-54. Haematologica. 1990. PMID: 1694155

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

438 results

Search Page

Filters